Ipratropium and Albuterol Inhaler

Using an ipratropium and albuterol inhaler four times a day can help treat symptoms of chronic obstructive pulmonary disease. It combines two medications, which each work in different ways to open up the airways to the lungs. Because the ipratropium and albuterol inhaler is not suitable for everyone, you should talk to your healthcare provider about certain existing medical problems (such as seizures or high blood pressure).

What Is the Ipratropium and Albuterol Inhaler?

The ipratropium and albuterol inhaler (Combivent®) is a prescription medication used to prevent airway spasms (also known as bronchospasms) caused by chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. The ipratropium and albuterol inhaler contains a combination of two medications: ipratropium bromide (Atrovent®) and albuterol sulfate (Proair®, Proventil®, Ventolin®). The ipratropium and albuterol inhaler is approved for treating COPD in people who still have breathing problems after trying one of these medications.
In order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer, Combivent inhalers (in their original form) will not be available after July 2013 because they contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. A new formulation, Combivent Respimat, became available starting in October 2012. People using the old Combivent inhaler will need to get a new prescription in order to switch to the new Combivent Respimat inhaler.
(Click What Is Ipratropium and Albuterol Inhaler Used For? for more information, including possible off-label uses.)

Information on Ipratropium and Albuterol

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.